SEC Comment Letter for Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069) (TLSA) — Jan 28, 2020
Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)
Date: Jan. 28, 2020 · CIK: 0001723069 · Accession: 0000000000-20-000733
AI Filing Summary & Sentiment
File numbers found in text: 333-236013
Letter
January 27, 2020 Kunwar Shailubhai, Ph.D., M.B.A Chief Executive Officer Tiziana Life Sciences plc 20 Lexington Avenue, Suite 2525 New York, NY 10170 Re:Tiziana Life Sciences plc Registration Statement on Form F-3 Filed January 22, 2020 File No. 333-236013 Dear Dr. Shailubhai: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey J. Fessler, Esq.
Show Raw Text
January 27, 2020
Kunwar Shailubhai, Ph.D., M.B.A
Chief Executive Officer
Tiziana Life Sciences plc
20 Lexington Avenue, Suite 2525
New York, NY 10170
Re:Tiziana Life Sciences plc
Registration Statement on Form F-3
Filed January 22, 2020
File No. 333-236013
Dear Dr. Shailubhai:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jeffrey J. Fessler, Esq.